Disease landscape

Atopic Dermatitis clinical trials

Get alerts when Atopic Dermatitis trials change

329 active trials 174 recruiting 52 Phase 3 210 sponsors 66 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days showing 40 of 66 changes on 20 trials

2026-08-28
Primary completion pushed: 2025-10-30 → 2028-02-17
Recruitment opened
Completion pushed: 2025-12-30 → 2028-03-30
NCT06931990 A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158… · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Phase 1/2
2026-08-28
Primary completion pushed: 2025-03-31 → 2025-11-25
Trial completed
Enrollment increased: 127 → 150 participants
Completion pushed: 2025-06-01 → 2025-11-25
NCT06082323 A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult… · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Phase 1
2026-08-07
Primary completion pushed: 2029-11 → 2030-07
Completion pushed: 2029-11 → 2030-07
NCT06461897 A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… · AbbVie · Phase 3
2026-08-05
Primary completion pushed: 2026-05-01 → 2027-08-01
Trial status changed: Active, Not Recruiting → Enrolling by Invitation
Completion pushed: 2026-12-31 → 2027-12-31
NCT06994520 Efficacy of Topical Cannabidiol for Eczema · Khon Kaen University · Phase 2
2026-08-06
Primary completion pushed: 2026-09-30 → 2026-12-30
Recruitment opened
NCT07228962 Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies · King's College London
2026-08-05
Primary completion pushed: 2026-07 → 2027-01
Completion pushed: 2027-07 → 2027-11
NCT06244212 Topical Treatment for Atopic Dermatitis · Wake Forest University Health Sciences
2026-08-14
Primary endpoint(s) modified
Enrollment increased: 150 → 230 participants
NCT06192563 A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less… · Sanofi
2026-08-25
Primary endpoint(s) modified
NCT07746427 Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis · Weill Medical College of Cornell University
2026-08-28
Recruitment opened
NCT07370909 Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients… · Shanghai Longwood Biopharmaceuticals Co., Ltd. · Phase 3
2026-08-25
Trial completed
Primary completion pushed: 2026-04 → 2026-06-26
Completion pushed: 2026-04 → 2026-06-26
NCT07264335 A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using… · Guangdong Hengrui Pharmaceutical Co., Ltd · Phase 1
2026-08-18
Recruitment opened
NCT07542483 A Study of Lebrikizumab in Adults With Nummular Eczema · Almirall, S.A. · Phase 3
2026-08-27
Trial status changed: Enrolling by Invitation → Recruiting
NCT04504955 CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and… · CorEvitas
2026-08-27
Recruitment opened
NCT07598058 PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry · CorEvitas
2026-08-13
Enrollment closed, study ongoing
Primary completion moved earlier: 2028-01 → 2027-08
Completion moved earlier: 2028-01 → 2027-08
NCT07265479 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3… · Organon and Co · Phase 3
2026-08-06
Trial completed
NCT03952559 A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis · Eli Lilly and Company · Phase 3
2026-08-19
Trial completed
Primary completion moved earlier: 2027-01-30 → 2026-06-22
Completion moved earlier: 2027-01-30 → 2026-06-22
NCT06353087 Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT… · Pfizer
2026-08-15
Recruitment opened
NCT07660835 Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months… · Galderma R&D · Phase 2
2026-08-14
Recruitment opened
NCT07560618 Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over… · Integrative Skin Science and Research · Phase 4
2026-08-07
Recruitment opened
Trial sites expanded: 1 → 9 locations
NCT07643766 A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults… · Enveda Therapeutics · Phase 2
2026-08-04
Completed without a posted recruiting period
Primary completion moved earlier: 2027-07-16 → 2026-03-09
Completion moved earlier: 2027-12-16 → 2026-04-29
NCT07103174 A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic… · Shanghai Mabgeek Biotech.Co.Ltd · Phase 2

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-08-10 NCT07754968 Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic… University of Roma La Sapienza new
2026-08-05 NCT07746817 A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic… Bionyra Pharma new Phase 1
2026-08-05 NCT07746427 Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis Weill Medical College of Cornell University new
2026-08-04 NCT07744516 Clinical Trial to Evaluate the Efficacy and Safety of an Ozonated Oil in Atopic Dermatitis Laboratorios Ozoaqua new
2026-08-03 NCT07742241 Efficacy Study of a Repairing Cream in Atopic Dermatitis Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L. new
2026-07-17 NCT07712536 Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent… E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. new Phase 2
2026-07-14 NCT07701447 Efficacy and Tolerability of a Probiotic Ointment BioGaia AB new
2026-07-14 NCT07703215 NPQ Plus Supplementation for Skin Health and Antioxidant Status N REMEDIER (M) SDN BHD new
2026-07-14 NCT07700745 A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery… Rejuvaskin new
2026-07-13 NCT07698756 A Clinical Study of HRS-8797 in Healthy Participants Chengdu Suncadia Medicine Co., Ltd. new Phase 1

Active trials by phase

Early Phase 1
1
Phase 1
31
Phase 1/2
4
Phase 2
61
Phase 2/3
3
Phase 3
49
Phase 4
21
Not charted: 159 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 329

NCT IDTitleSponsorStatusUpdated
Phase 4
NCT07560618 Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over… Integrative Skin Science and Research Recruiting 2026-08-13
NCT05858619 Molecular Signatures of Cutaneous Dupilumab Response University of California, San Francisco Recruiting 2026-06-04
NCT05042258 Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With… Northwestern University Recruiting 2026-04-27
NCT06116526 Dupilumab De-escalation in Pediatric Atopic Dermatitis Johns Hopkins University Recruiting 2026-04-20
NCT05268107 Ethnic Differences in Mechanisms of Action of Dupilumab University of Michigan Recruiting 2025-11-06
NCT06004986 DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting 2025-10-08
NCT06906497 Lebrikizumab in Moderate-to-severe Atopic Dermatitis Johann E Gudjonsson MD PhD Recruiting 2025-08-11
NCT05758532 Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and… Laure Pittet, MD-PhD Recruiting 2024-05-29
NCT05285839 Dupixent and Narrowband UVB for Atopic Dermatitis Psoriasis Treatment Center of Central New Jersey Recruiting 2024-03-15
NCT07713186 Azithromycin in Atopic Dermatitis Cairo University Not Yet Recruiting 2026-07-20
NCT07661979 Opzelura Experience Study Wake Forest University Health Sciences Not Yet Recruiting 2026-07-14
NCT07447063 The Impact of Dietary Salt on the Severity of Eczema University of California, San Francisco Not Yet Recruiting 2026-06-09
NCT07487831 The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease University of California, San Francisco Not Yet Recruiting 2026-06-09
NCT07352566 Utilization of a Microdevice for Psoriasis and Atopic Dermatitis University of California, San Francisco Not Yet Recruiting 2026-06-03
NCT07006792 A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic… Eli Lilly and Company Active, Not Recruiting 2026-05-22
NCT06397781 Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients Boston Children's Hospital Not Yet Recruiting 2026-03-10
NCT07438509 Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema Jinnah Postgraduate Medical Centre Not Yet Recruiting 2026-03-06
NCT05566262 Bodewell Products for the Treatment of Atopic Dermatitis University of Alabama at Birmingham Active, Not Recruiting 2026-03-02
NCT07437534 Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%)… Hayat Abad Medical Complex, Peshawar Not Yet Recruiting 2026-03-02
NCT07367932 Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis Cairo University Not Yet Recruiting 2026-01-26
NCT05642208 Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With… Nantes University Hospital Active, Not Recruiting 2025-09-11
Phase 3
NCT07370909 Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients… Shanghai Longwood Biopharmaceuticals Co., Ltd. Recruiting 2026-08-27
NCT06807268 A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age… Pfizer Recruiting 2026-08-17
NCT06807281 A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older… Pfizer Recruiting 2026-08-17
NCT07542483 A Study of Lebrikizumab in Adults With Nummular Eczema Almirall, S.A. Recruiting 2026-08-17
See all 329 active Atopic Dermatitis trials with filters →

Top sponsors by active trials in this area

Pfizer (12) · AbbVie (10) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Sanofi (7) · Keymed Biosciences Co.Ltd (5) · University of California, San Francisco (5) · Eli Lilly and Company (4) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (4) · Galderma R&D (4) · Guangdong Hengrui Pharmaceutical Co., Ltd (4)

Get alerts when Atopic Dermatitis trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free